4.7 Review

Self-reactive IgE and anti-IgE therapy in autoimmune diseases

Related references

Note: Only part of the references are listed.
Article Allergy

Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3+ Treg generation

Cristina Benito-Villalvilla et al.

Summary: Ligelizumab has a stronger capacity than omalizumab to regulate functional properties of plasmacytoid dendritic cells (pDCs), including the blocking of IgE binding to Fc epsilon RI and the restoration of IFN-alpha production and Treg generation. These findings provide important clinical implications for anti-IgE treatments in different IgE-mediated diseases.

ALLERGY (2023)

Article Allergy

Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study

Marcus Maurer et al.

Summary: The long-term safety and re-treatment efficacy of ligelizumab 240 mg in patients with chronic spontaneous urticaria were demonstrated, with the majority of patients achieving complete response after 52 weeks. Ligelizumab was well-tolerated with most adverse events being mild or moderate, and consistent with the core study results.

ALLERGY (2022)

Review Allergy

Epithelial barrier hypothesis: Effect of external exposome on microbiome and epithelial barriers in allergic disease

Zeynep Celebi Sozener et al.

Summary: Environmental exposure plays a major role in the development of allergic diseases, including climate change, pollution, changes and loss of biodiversity, etc. The epithelial barrier hypothesis provides a mechanistic explanation of how these factors contribute to the increase in allergic and autoimmune diseases. Measures should be taken to mitigate environmental threats and decrease allergic diseases.

ALLERGY (2022)

Review Dermatology

Global incidence and prevalence of bullous pemphigoid: A systematic review and meta-analysis

Lingling Lu et al.

Summary: This study estimated the global incidence and prevalence of bullous pemphigoid (BP) through a systematic review and meta-analysis. The findings showed that BP incidence was relatively higher in Europe, females, older people, and high-income countries, while the prevalence was higher in Asia. However, caution should be exercised when interpreting these findings due to high between-study heterogeneity.

JOURNAL OF COSMETIC DERMATOLOGY (2022)

Article Allergy

The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Torsten Zuberbier et al.

Summary: The updated international guideline for urticaria was developed jointly by multiple international organizations, with participants from 50 countries and international societies, aiming to provide expert guidance on diagnostic and therapeutic approaches for different subtypes of urticaria.

ALLERGY (2022)

Review Medicine, General & Internal

Omalizumab for STAT3 Hyper-IgE Syndromes in Adulthood: A Case Report and Literature Review

Jun Lan et al.

Summary: This article describes a case of a HIES patient who benefited from omalizumab treatment, showing improvement in symptoms.

FRONTIERS IN MEDICINE (2022)

Article Rheumatology

Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations

Rory C. Monahan et al.

Summary: This study found the presence of anti-PTM antibodies against MAA, AGE, and CarP modified proteins in SLE and NPSLE. Interestingly, anti-MAA and anti-CarP were more prevalent in NPSLE, a manifestation that lacks serological markers.

RMD OPEN (2022)

Letter Dermatology

Omalizumab as adjuvant therapy for pemphigus vulgaris

Antonio Ji-Xu et al.

DERMATOLOGIC THERAPY (2022)

Article Allergy

Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria

Martin Metz et al.

Summary: In this study, ligelizumab effectively reduced angioedema and urticaria symptoms in patients with CSU, and improved health-related quality of life.

WORLD ALLERGY ORGANIZATION JOURNAL (2022)

Review Immunology

Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis

Malik R. Seals et al.

Summary: This article provides an updated review on the role of B cells and antibody response in multiple sclerosis and its murine model, experimental autoimmune encephalomyelitis (EAE). It focuses on the regulation of antibody-producing B cells and discusses the potential role of IgE antibody in microglia and macrophage activation, autoimmunity, and the development of MS/EAE.

FRONTIERS IN IMMUNOLOGY (2022)

Review Allergy

A new autoimmune disease: atopic dermatitis in children

Emanuela Floca et al.

Summary: This article investigates the existence of autoimmune components in atopic dermatitis (AD). Through literature analysis and research, it is found that AD patients have similar clinical manifestations to other autoimmune diseases, and there is correlation between AD and other autoimmune diseases. AD patients may also have comorbidities of other autoimmune diseases. Three major factors contribute to the pathogenesis of AD, suggesting that AD may be classified as an autoimmune disease.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2022)

Article Dermatology

Omalizumab as a corticosteroid-sparing agent in the treatment of bullous pemphigoid

Camilla Vassallo et al.

Summary: Omalizumab has shown promising results in treating bullous pemphigoid, reducing the dependency on systemic corticosteroids and improving clinical symptoms and blood markers.

DERMATOLOGIC THERAPY (2022)

Article Allergy

Comparison of the Patients with Chronic Urticaria Who Responded and Did Not Respond to Omalizumab Treatment: A Single-Center Retrospective Study

Mehmet Erdem Cakmak

Summary: This study on patients with chronic urticaria (CU) found that those who responded well to Omalizumab treatment often had atopic conditions with high eosinophil, basophil, and total IgE levels, while patients with concomitant psychiatric disorders and positive thyroid autoantibodies had a poor response to Omalizumab treatment.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2022)

Article Immunology

Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus

Xin Jin et al.

Summary: This study found significant differences in the frequency of cTfh cell subsets and associated B cell subsets between active and inactive SLE patients, with elevated levels of cytokines associated with cTfh cells in active SLE patients. Additionally, Tfh cell subsets and plasmablasts may have important roles in the pathogenesis of SLE and could be potential targets for therapeutic interventions.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, Research & Experimental

IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms

Be-Sheng Kuo et al.

Summary: Over the past 20 years, only omalizumab has been approved as an anti-IgE antibody for treating asthma and chronic spontaneous urticaria (CSU). This report introduces UB-221, a newer class of anti-IgE antibody with different characteristics compared to omalizumab and ligelizumab. UB-221 demonstrates superior efficacy in CD23-mediated downregulation of IgE production and exhibits strong IgE-neutralizing activity.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Letter Respiratory System

Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs

Jacobo Lopez-Abente et al.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Allergy

Lupus-like autoimmunity and increased interferon response in patients with STAT3-deficient hyper-IgE syndrome

Rishi R. Goel et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Allergy

Basophils and IgE contribute to mixed connective tissue disease development

Yasmine Lamri et al.

Summary: MCTD is a rare and complex autoimmune disease with high levels of anti-U1 small nuclear ribonucleoprotein 70k autoantibodies. Basophils and IgE play a role in MCTD pathophysiology and may serve as therapeutic targets for patients. Basophil activation and autoreactive IgE against U1 small nuclear ribonucleoprotein 70k were observed in both patients and an MCTD-like mouse model.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Review Immunology

Autoimmunity, IgE and FceRI-bearing cells

Nicolas Charles

Summary: Antibody-mediated autoimmune diseases involve various autoreactive antibodies, with IgE playing a significant role in some cases. Cells bearing FceRI, such as basophils or mast cells, are crucial in these diseases. Advancements in pathophysiology have led to the development of anti-IgE strategies that show promising effects in certain conditions.

CURRENT OPINION IN IMMUNOLOGY (2021)

Review Immunology

Intrinsic and extrinsic regulation of IgE B cell responses

Adam K. Wade-Vallance et al.

Summary: Stringent regulation of IgE antibody production is crucial in constraining allergic responses. Both cell-intrinsic and extrinsic mechanisms play important roles in regulating the genesis and fate of IgE B cells, with IgE B Cell Receptor and T follicular helper cells being key players. Various cytokines produced by T-FH, such as IL-4 and IL-21, are essential in activating or inhibiting IgE class-switching. Recent studies have also found conditions that disrupt the normal constraints on IgE responses, leading to enhanced or prolonged IgE responses.

CURRENT OPINION IN IMMUNOLOGY (2021)

Article Allergy

Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab

Donald MacGlashan et al.

Summary: This study examined changes in basophil function and its relationship to auto-antibodies during treatment with omalizumab in patients with chronic spontaneous urticaria (CSU). Results suggest that the presence of auto-antibodies may affect basophil numbers and function in patients treated with omalizumab.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Polymorphic estrogen receptor binding site causes Cd2-dependent sex bias in the susceptibility to autoimmune diseases

Gonzalo Fernandez Lahore et al.

Summary: Complex autoimmune diseases exhibit sexual dimorphism possibly controlled by an interplay between genetics and sex-related factors. Reduced CD2 expression in female mice affects autoreactive T cell responses, with hormonal regulation of CD2 also playing a role in human T cells. The study highlights the relevance of sex-genotype interactions and identifies CD2 as a predisposing factor in autoimmune diseases.

NATURE COMMUNICATIONS (2021)

Letter Allergy

Rheumatoid arthritis-like polyarthralgia after the initiation of omalizumab treatment: A case series

Yasuo To et al.

Summary: Clinicians should consider the potential development of RA-like polyarthralgia in patients treated with omalizumab. Serological markers of RA may help identify patients who are susceptible to these adverse events.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Review Immunology

Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?

Cezmi A. Akdis

Summary: The increase in allergic, autoimmune, and chronic diseases may be related to epithelial barrier-damaging agents associated with industrialization, urbanization, and modern life. These diseases are more prevalent in industrialized countries and are on the rise in developing countries, affecting over one billion people globally.

NATURE REVIEWS IMMUNOLOGY (2021)

Editorial Material Allergy

Omalizumab in the Treatment of Hyper-IgE Syndrome: 2 Case Reports

N. Gomes et al.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2020)

Article Allergy

The role of eosinophils in chronic spontaneous urticaria

Sabine Altrichter et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Dermatology

Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria

L. Yu et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

Article Medicine, General & Internal

Ligelizumab for Chronic Spontaneous Urticaria

Marcus Maurer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Allergy

IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria

Oliver Schmetzer et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Article Dermatology

Epidemiology of adult atopic dermatitis

Ryan Sacotte et al.

CLINICS IN DERMATOLOGY (2018)

Review Immunology

The role and relevance of mast cells in urticaria

Martin K. Church et al.

IMMUNOLOGICAL REVIEWS (2018)

Article Allergy

Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry

Yael Gernez et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)

Review Dermatology

Omalizumab for atopic dermatitis: case series and a systematic review of the literature

Jesper Gronlund Holm et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2017)

Letter Allergy

Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria

Janine Gericke et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Article Dermatology

Autoimmune diseases in adults with atopic dermatitis

Yuki M. F. Andersen et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Editorial Material Medicine, General & Internal

CLINICAL UPDATES Bullous pemphigoid and pemphigus vulgaris

Mahaz Kayani et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Editorial Material Medicine, General & Internal

CLINICAL UPDATES Bullous pemphigoid and pemphigus vulgaris

Mahaz Kayani et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Review Immunology

The multiple pathways to autoimmunity

Argyrios N. Theofilopoulos et al.

NATURE IMMUNOLOGY (2017)

Letter Dermatology

Omalizumab for the treatment of hyperimmunoglobulin E syndrome: A 12-year-old case

Piril Etikan Akbas et al.

DERMATOLOGICA SINICA (2017)

Review Immunology

IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases

Nina van Beek et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)

Article Allergy

Role of IgE in autoimmunity

Miguel A. Sanjuan et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Article Allergy

IgE epitope proximity determines immune complex shape and effector cell activation capacity

Anna Gieras et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Letter Allergy

Efficacy of omalizumab in patients with atopic dermatitis: A systematic review andmeta-analysis

Hsiao-Han Wang et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Article Allergy

Autoreactive T cells in chronic spontaneous urticaria target the IgE Fc receptor Iα subunit

Priscilla Auyeung et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Letter Allergy

A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria

Jeffrey M. Harris et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Review Immunology

Autoantibodies in SLE: Specificities, Isotypes and Receptors

Barbara Dema et al.

ANTIBODIES (2016)

Article Endocrinology & Metabolism

Atopic Dermatitis: Global Epidemiology and Risk Factors

Sophie Nutten

ANNALS OF NUTRITION AND METABOLISM (2015)

Review Medicine, Research & Experimental

Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity

Jolien Suurmond et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Immunology

A single glycan on IgE is indispensable for initiation of anaphylaxis

Kai-Ting C. Shade et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Editorial Material Dermatology

Omalizumab, an Anti-IgE mAb, Receives Approval for the Treatment of Chronic Idiopathic/Spontaneous Urticaria

Keith C. P. Wu et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)

Article Immunology

Immunoglobulin E plays an immunoregulatory role in lupus

Barbara Dema et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2014)

Article Immunology

CD3G Gene Defects in Familial Autoimmune Thyroiditis

B. Gokturk et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2014)

Article Medicine, General & Internal

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

Marcus Maurer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Dermatology

Successful Treatment of Bullous Pemphigoid With Omalizumab

Vanessa A. London et al.

ARCHIVES OF DERMATOLOGY (2012)

Letter Dermatology

Successful management of severe infant bullous pemphigoid with omalizumab

C. Dufour et al.

BRITISH JOURNAL OF DERMATOLOGY (2012)

Article Allergy

Does autoreactivity'' play a role in atopic dermatitis?

Ting Seng Tang et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Article Allergy

Chronic urticaria and autoimmunity: Associations found in a large population study

Ronit Confino-Cohen et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Article Immunology

Sequential class switching is required for the generation of high affinity IgE antibodies

Huizhong Xiong et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2012)

Review Genetics & Heredity

The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome

Eva d'Hennezel et al.

JOURNAL OF MEDICAL GENETICS (2012)

Review Biochemistry & Molecular Biology

IgE and mast cells in allergic disease

Stephen J. Galli et al.

NATURE MEDICINE (2012)

Article Allergy

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase

Marcus Maurer et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Article Multidisciplinary Sciences

A Soluble Form of the High Affinity IgE Receptor, Fc-Epsilon-RI, Circulates in Human Serum

Eleonora Dehlink et al.

PLOS ONE (2011)

Review Immunology

CD23/Fc epsilon RII: molecular multi-tasking

M. Acharya et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)

Article Allergy

Autoimmune Response of IgE Antibodies to Cellular Self-Antigens in Systemic Lupus Erythematosus

Ajax Merces Atta et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2010)

Article Biochemistry & Molecular Biology

Basophils and the T helper 2 environment can promote the development of lupus nephritis

Nicolas Charles et al.

NATURE MEDICINE (2010)

Article Dermatology

IgE autoantibodies against the intracellular domain of BP180

S. K. Dresow et al.

BRITISH JOURNAL OF DERMATOLOGY (2009)

Review Immunology

Follicular helper T cells as cognate regulators of B cell immunity

Louise J. McHeyzer-Williams et al.

CURRENT OPINION IN IMMUNOLOGY (2009)

Article Allergy

Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema

Sabine Zeller et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)

Letter Allergy

Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab

Janet A. Fairley et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)

Meeting Abstract Allergy

Omalizumab therapy for Hyper-IgE syndrome

G. V. Marcotte

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)

Article Dermatology

Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid

Nobuko Ishiura et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2008)

Letter Dermatology

Bullous Pemphigoid Autoantibodies Preferentially Recognize Phosphoepitopes in Collagen XVII

Elena P. Zimina et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)

Article Immunology

The structure of human CD23 and its interactions with IgE and CD21

RG Hibbert et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)

Letter Allergy

The cradle of IgE autoreactivity in atopic eczema lies in early infancy

N Mothes et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)

Article Immunology

Basophils initiate IL-4 production during a memory T-dependent response

MV Khodoun et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2004)

Article Rheumatology

Possible importance of immunoglobulin E in foetal loss by mothers with anti-SSA antibody

I Sekigawa et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2004)

Article Allergy

Mechanisms of autoimmune activation of basophils in chronic urticaria

Y Kikuchi et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)

Article Allergy

Thyroid autoimmunity in chronic urticaria

D Zauli et al.

ALLERGY AND ASTHMA PROCEEDINGS (2001)